Immunological fingerprinting of group B streptococci: From circulating human antibodies to protective antigens (Q44592867)

4 December 2017

title

Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens (English)

1 reference

4 December 2017

Immunological fingerprinting of group B streptococci: From circulating human antibodies to protective antigens (English)

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.08.041

21 June 2024

1 reference

Zehra Visram

1 reference

4 December 2017

Duc Bui Minh

1 reference

4 December 2017

Wolfgang Schüler

1 reference

4 December 2017

Christina Neubauer

1 reference

4 December 2017

Dieter Gelbmann

1 reference

4 December 2017

Birgit Noiges

1 reference

4 December 2017

Jan Sinzinger

1 reference

4 December 2017

Markus Hanner

1 reference

4 December 2017

Shailesh Dewasthaly

1 reference

4 December 2017

Urban Lundberg

1 reference

4 December 2017

Knut Hordnes

1 reference

4 December 2017

Helga Masoud

1 reference

4 December 2017

Paul Sevelda

1 reference

4 December 2017

Alexander von Gabain

1 reference

4 December 2017

Eszter Nagy

1 reference

4 December 2017

Andreas L. Meinke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732466

21 June 2024

Beatrice M. Senn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732466

21 June 2024

Tamás Z. Henics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732466

21 June 2024

language of work or name

English

0 references

publication date

21 August 2010

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0264410X10011862?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.08.041

https://api.elsevier.com/content/article/PII:S0264410X10011862?httpAccept=text/plain

21 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.08.041

21 June 2024

1 reference

4 December 2017

1 reference

4 December 2017

1 reference

4 December 2017

page(s)

6997-7008

1 reference

Invasive group B Streptococcal disease in non-pregnant adults : a review with emphasis on skin and soft-tissue infections

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Group B Streptococcus: global incidence and vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Group B streptococcal conjugate vaccine: a timely concept for which the time has come

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Recent advances in understanding the molecular basis of group B Streptococcus virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Group B streptococcal conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Glycoconjugate vaccines to prevent group B streptococcal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Identification of group B streptococcal Sip protein, which elicits cross-protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Identification of major outer surface proteins of Streptococcus agalactiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Identification of a universal Group B streptococcus vaccine by multiple genome screen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Genome Analysis Reveals Pili in Group B Streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Assembly and role of pili in group B streptococci.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Composition of the ANTIGENome of Helicobacter pylori defined by human serum antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Relevance of peptide uptake systems to the physiology and virulence of Streptococcus agalactiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Bacterial phage receptors, versatile tools for display of polypeptides on the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Small-fragment genomic libraries for the display of putative epitopes from clinically significant pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Serotype identification of group B streptococci by PCR and sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Use of a serotype-specific DNA microarray for identification of group B Streptococcus (Streptococcus agalactiae)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

A nondegradative route for the removal of endotoxin from exopolysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Efficient insertional mutagenesis in lactococci and other gram-positive bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Identification and molecular analysis of PcsB, a protein required for cell wall separation of group B streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

FbsA, a fibrinogen-binding protein from Streptococcus agalactiae, mediates platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen-binding protein FbsA of Streptococcus agalactiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Genetic islands of Streptococcus agalactiae strains NEM316 and 2603VR and their presence in other Group B streptococcal strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Genomic diversity and evolution within the species Streptococcus agalactiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

BibA Induces Opsonizing Antibodies Conferring In Vivo Protection against Group BStreptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Group B streptococcal infections in elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Role of fibrinogen-binding adhesin expression in septic arthritis and septicemia caused by Streptococcus agalactiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Rapid detection of the “highly virulent” group B streptococcus ST-17 clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Basic local alignment search tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Clustal W and Clustal X version 2.0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

T-Coffee: A novel method for fast and accurate multiple sequence alignment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Jalview Version 2--a multiple sequence alignment editor and analysis workbench

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.041

Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.08.041

21 June 2024

Identifiers

1 reference

4 December 2017

1 reference